{"disease":{"id":"gout","name":"Gout","therapeutic_area":"Rheumatology","data":{"aiSummary":"The treatment landscape for gout involves managing acute flares with anti-inflammatory agents and preventing future flares through urate-lowering therapy (ULT). Marketed drugs include NSAIDs, colchicine, and xanthine oxidase inhibitors like allopurinol and febuxostat. Pegloticase is available for refractory cases. The pipeline includes novel formulations of existing drugs and new approaches like SEL-212. Recent advances focus on improving ULT adherence and reducing cardiovascular risk associated with gout.","drug_count":11,"description":"Gout is a form of inflammatory arthritis caused by the deposition of monosodium urate crystals in joints and other tissues. This occurs due to hyperuricemia, an elevated level of uric acid in the blood. The resulting inflammation leads to painful attacks, known as gout flares, and can cause chronic joint damage if left untreated.","subtype_count":8},"enrichment_level":2,"last_enriched_at":null,"visit_count":0,"created_at":"2026-03-25T12:16:34.929Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":13,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"canakinumab","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ilaris","generic_name":"CANAKINUMAB","company_name":"Novartis Pharms","drug_phase":"marketed","molecular_target":"Interleukin-1 beta","drug_class":"Non-Standardized Plant Allergenic Extract [EPC]","quality_score":59,"revenue":"1369","mechanism":""},{"drug_id":"krystexxa","indication_name":"Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"KRYSTEXXA®","company_name":"Selecta Biosciences, Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":"900","mechanism":"Krystexxa works by targeting a specific biological pathway to treat a particular condition."},{"drug_id":"meclofenamic-acid","indication_name":"Acute Gouty Arthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Meclofenamate","generic_name":"MECLOFENAMIC ACID","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"meclofenamic acid","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"nsaids-ibubrofen-aspirin","indication_name":"Acute Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"NSAIDs \"ibubrofen,Aspirin\"","company_name":"Assiut University","drug_phase":"marketed","molecular_target":"","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"xzp-5610-tablet-for-part-c2","indication_name":"Acute Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"XZP-5610 Tablet for \"Part C2\"","company_name":"Xuanzhu Biopharmaceutical Co., Ltd.","drug_phase":"marketed","molecular_target":"","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"multiple-visit-corticosteroid-paste","indication_name":"Acute Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Multiple-Visit-\"Corticosteroid Paste\"","company_name":"Istanbul Medipol University Hospital","drug_phase":"marketed","molecular_target":"cyclooxygenase (COX-1 and COX-2)","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":45,"revenue":null,"mechanism":"Naproxen reduces pain, inflammation, and fever by inhibiting prostaglandin synthesis through COX-1 and COX-2 inhibition."},{"drug_id":"febuxostat-tablets","indication_name":"Chronic management of hyperuricemia in gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Febuxostat Tablets","company_name":"Mostafa Bahaa","drug_phase":"marketed","molecular_target":"","drug_class":"Xanthine Oxidase Inhibitor [EPC]","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"topiroxostat","indication_name":"Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Uriadec","generic_name":"TOPIROXOSTAT","company_name":"Senwa Kegaku Kenkyushp","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, Xanthine dehydrogenase/oxidase, Xanthine dehydrogenase/oxidase","drug_class":"","quality_score":17,"revenue":null,"mechanism":null},{"drug_id":"hydrocortisone-succinate","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Solu-Cortef","generic_name":"hydrocortisone succinate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"dotinurad","indication_name":"Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Urece","generic_name":"DOTINURAD","company_name":"Fuji Yakuhin","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 12","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone-acetate","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortifoam","generic_name":"HYDROCORTISONE ACETATE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"betamethasone-acetate","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Celestone Soluspan","generic_name":"BETAMETHASONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Decadron","generic_name":"dexamethasone","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"Annexin A1, Interleukin-4, Androgen receptor","drug_class":"Corticosteroid [EPC]","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"cinchophen","indication_name":"Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cincain","generic_name":"CINCHOPHEN","company_name":"","drug_phase":"marketed","molecular_target":"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","drug_class":"cinchophen","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"colchicine","indication_name":"Chronic gouty arthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Colcrys","generic_name":"COLCHICINE","company_name":"Scilex Pharms","drug_phase":"marketed","molecular_target":"Serine/threonine-protein kinase pim-1","drug_class":"Alkaloid [EPC]","quality_score":10,"revenue":null,"mechanism":"Colcrys works by inhibiting the activity of a specific enzyme called serine/threonine-protein kinase pim-1."},{"drug_id":"colchicine","indication_name":"Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Colcrys","generic_name":"COLCHICINE","company_name":"Scilex Pharms","drug_phase":"marketed","molecular_target":"Serine/threonine-protein kinase pim-1","drug_class":"Alkaloid [EPC]","quality_score":10,"revenue":null,"mechanism":"Colcrys works by inhibiting the activity of a specific enzyme called serine/threonine-protein kinase pim-1."},{"drug_id":"colchicine","indication_name":"Gout Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Colcrys","generic_name":"COLCHICINE","company_name":"Scilex Pharms","drug_phase":"marketed","molecular_target":"Serine/threonine-protein kinase pim-1","drug_class":"Alkaloid [EPC]","quality_score":10,"revenue":null,"mechanism":"Colcrys works by inhibiting the activity of a specific enzyme called serine/threonine-protein kinase pim-1."},{"drug_id":"indom","indication_name":"Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Indom","company_name":"University of Trieste","drug_phase":"marketed","molecular_target":"Aldo-keto reductase family 1 member C4, Dehydrogenase/reductase SDR family member 9, Nicotinate phosphoribosyltransferase","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"prednison","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednison","company_name":"Wen Zhang","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"methylprednisolone","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Medrol","generic_name":"methylprednisolone","company_name":"Generic (originally Upjohn/Pfizer)","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"Glucocorticoid (corticosteroid)","quality_score":62,"revenue":null,"mechanism":"Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions."},{"drug_id":"hydrocortisone","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"azapropazone","indication_name":"Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Apazone","generic_name":"azapropazone","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 1","drug_class":"azapropazone","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"triamcinolone","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rodinolone","generic_name":"TRIAMCINOLONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"adenuric","indication_name":"Gout Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Adenuric","company_name":"Pharmtechnology LLC","drug_phase":"phase_3","molecular_target":"Flavin reductase (NADPH), ATP-binding cassette sub-family G member 2, Potassium voltage-gated channel subfamily H member 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisone","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"indomethacin","indication_name":"Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Indocin Sr","generic_name":"INDOMETHACIN","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin E2 receptor EP2 subtype","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":80,"revenue":null,"mechanism":"Indomethacin works by blocking the production of prostaglandins, which are hormone-like substances that cause pain and inflammation."},{"drug_id":"febuxostat","indication_name":"Gout Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Uloric","generic_name":"FEBUXOSTAT","company_name":"Takeda","drug_phase":"marketed","molecular_target":"Xanthine dehydrogenase/oxidase","drug_class":"Xanthine Oxidase Inhibitor [EPC]","quality_score":65,"revenue":null,"mechanism":"Uloric works by blocking the enzyme xanthine dehydrogenase/oxidase, which is involved in the production of uric acid."},{"drug_id":"allopurinol","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aloprim","generic_name":"ALLOPURINOL","company_name":"Casper Pharma Llc","drug_phase":"marketed","molecular_target":"Xanthine dehydrogenase/oxidase","drug_class":"Xanthine Oxidase Inhibitor [EPC]","quality_score":70,"revenue":null,"mechanism":"Aloprim works by inhibiting the enzyme xanthine oxidase, which is responsible for producing uric acid in the body."},{"drug_id":"allopurinol","indication_name":"Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aloprim","generic_name":"ALLOPURINOL","company_name":"Casper Pharma Llc","drug_phase":"marketed","molecular_target":"Xanthine dehydrogenase/oxidase","drug_class":"Xanthine Oxidase Inhibitor [EPC]","quality_score":70,"revenue":null,"mechanism":"Aloprim works by inhibiting the enzyme xanthine oxidase, which is responsible for producing uric acid in the body."},{"drug_id":"allopurinol","indication_name":"Uric Acid Nephropathy Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aloprim","generic_name":"ALLOPURINOL","company_name":"Casper Pharma Llc","drug_phase":"marketed","molecular_target":"Xanthine dehydrogenase/oxidase","drug_class":"Xanthine Oxidase Inhibitor [EPC]","quality_score":70,"revenue":null,"mechanism":"Aloprim works by inhibiting the enzyme xanthine oxidase, which is responsible for producing uric acid in the body."},{"drug_id":"intra-articular-corticosteroid-injections","indication_name":"Gouty arthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Intra-articular corticosteroid injections","generic_name":"intra-articular-corticosteroid-injections","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"probenecid","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Col-Probenecid","generic_name":"probenecid","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 9","drug_class":"probenecid","quality_score":10,"revenue":null,"mechanism":"ORLYNVAH combines sulopenem etzadroxil, a penem antibacterial, with probenecid to increase sulopenem's plasma concentration by inhibiting its renal clearance."},{"drug_id":"probenecid","indication_name":"Chronic gouty arthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Col-Probenecid","generic_name":"probenecid","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 9","drug_class":"probenecid","quality_score":10,"revenue":null,"mechanism":"ORLYNVAH combines sulopenem etzadroxil, a penem antibacterial, with probenecid to increase sulopenem's plasma concentration by inhibiting its renal clearance."},{"drug_id":"betamethasone","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Betametasone","generic_name":"BETAMETHASONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":65,"revenue":null,"mechanism":"Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system."},{"drug_id":"benzbromarone","indication_name":"Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Azubromaron","generic_name":"BENZBROMARONE","company_name":"","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C9","drug_class":"benzbromarone","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cortisol","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolone","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"benzbromaron","indication_name":"Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Benzbromaron","company_name":"Amsterdam UMC, location VUmc","drug_phase":"marketed","molecular_target":"Eyes absent homolog 2, Eyes absent homolog 3, ATP-binding cassette sub-family G member 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisolon","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"methylprednisolon","indication_name":"Articular gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Methylprednisolon","company_name":"Leiden University Medical Center","drug_phase":"marketed","molecular_target":"Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"indometacin","indication_name":"Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"indometacin","company_name":"Maastricht University Medical Center","drug_phase":"marketed","molecular_target":"Aldo-keto reductase family 1 member C4, Dehydrogenase/reductase SDR family member 9, Nicotinate phosphoribosyltransferase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"prednisone","indication_name":"Acute gouty arthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"naproxen","indication_name":"Gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aleve","generic_name":"naproxen","company_name":"Generic (originally Syntex)","drug_phase":"marketed","molecular_target":"Aldo-keto reductase family 1 member C2, Aldo-keto reductase family 1 member C3, Prostaglandin G/H synthase 1","drug_class":"NSAID","quality_score":null,"revenue":null,"mechanism":"Reversibly inhibits COX-1 and COX-2 with a long half-life, providing sustained anti-inflammatory, analgesic, and antipyretic effects."},{"drug_id":"dexamethasone-phosphate","indication_name":"Acute gouty arthritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":45,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03847753","title":"Exploring the Comorbidity Between Mental Disorders and General Medical Conditions","phase":"","overall_status":"COMPLETED","enrollment_count":5940299,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT04746989","title":"Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines - (DREAM) Probenecid vs Allopurinol","phase":"","overall_status":"COMPLETED","enrollment_count":294878,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":true},{"nct_id":"NCT01685424","title":"Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)","phase":"","overall_status":"COMPLETED","enrollment_count":79189,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT04853160","title":"Drug Use Study of Febuxostat After Recent Changes in the Prescribing Information","phase":"","overall_status":"COMPLETED","enrollment_count":24046,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT03470584","title":"Vegetarian Diet and Chronic Degenerative Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":18064,"lead_sponsor_name":"Dalin Tzu Chi General Hospital","has_results":false},{"nct_id":"NCT03047369","title":"The Myelin Disorders Biorepository Project","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT05586971","title":"Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2202,"lead_sponsor_name":"LG Chem","has_results":false},{"nct_id":"NCT06694012","title":"Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Osaka Metropolitan University","has_results":false},{"nct_id":"NCT05006001","title":"Evaluation of Colchicine and Nonsteroidal Anti-inflammatory Drug Combination Therapy and Renal Function in Gout Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"En Chu Kong Hospital","has_results":false},{"nct_id":"NCT05473325","title":"Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Willows Health","has_results":false},{"nct_id":"NCT05607797","title":"Genetic of Chronic Kidney Disease and Gout in New Caledonia","phase":"NA","overall_status":"COMPLETED","enrollment_count":1858,"lead_sponsor_name":"Lille Catholic University","has_results":false},{"nct_id":"NCT04812886","title":"Epidemiology of Gout in French Polynesia","phase":"NA","overall_status":"COMPLETED","enrollment_count":1088,"lead_sponsor_name":"Lille Catholic University","has_results":false},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT06092346","title":"A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":999,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT02579096","title":"CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":950,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT04953533","title":"Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of Gout","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04956432","title":"A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With Gout","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":779,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT06139393","title":"Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":765,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT04875702","title":"Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":650,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT07414394","title":"Tigulixostat (IBI128) vs Febuxostat in Gout","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Innovent Biologics Technology Limited (Shanghai R&D Center)","has_results":false},{"nct_id":"NCT04052932","title":"A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":594,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT05815901","title":"A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":588,"lead_sponsor_name":"JW Pharmaceutical","has_results":false},{"nct_id":"NCT05045742","title":"Prediction of Patient Deterioration Using Machine Learning","phase":"","overall_status":"COMPLETED","enrollment_count":526,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT07188285","title":"Mass Spectrometry-based Immune Profiling in Autoimmune Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT07089875","title":"A Study of Dotinurad Versus Allopurinol in Participants With Gout","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Crystalys Therapeutics","has_results":false},{"nct_id":"NCT06068478","title":"A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty Arthritis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":472,"lead_sponsor_name":"Tasly Pharmaceutical Group Co., Ltd","has_results":false},{"nct_id":"NCT05007392","title":"A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":451,"lead_sponsor_name":"Eisai Co., Ltd.","has_results":true},{"nct_id":"NCT07504146","title":"The Orienting Study","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio","has_results":false},{"nct_id":"NCT06956885","title":"Maintenance or Withdrawal of Urate Lowering Therapy According to Ultrasound Features in Gout Patients: a Randomised Controlled Trial Stop Treatment In Gout","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":450,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT01431638","title":"Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":397,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04519021","title":"Knowledge, Attitude and Practice Regarding Diagnosis and Management of Gout Among Clinicians in Nepal","phase":"","overall_status":"COMPLETED","enrollment_count":380,"lead_sponsor_name":"National Center for Rheumatic Diseases, Nepal","has_results":false},{"nct_id":"NCT04849312","title":"Prediction of 30-Day Readmission Using Machine Learning","phase":"","overall_status":"COMPLETED","enrollment_count":372,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT06834230","title":"Effect of Dotinurad in Hyperuricemia With Hypertension","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Saga University","has_results":false},{"nct_id":"NCT05586958","title":"Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":354,"lead_sponsor_name":"LG Chem","has_results":false},{"nct_id":"NCT04952896","title":"Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease","phase":"","overall_status":"COMPLETED","enrollment_count":350,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT00927810","title":"Long Term Study of Canakinumab (ACZ885) in Patients With Gout","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":341,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05983445","title":"Safety & Efffficacy of Genakumab in Patients With Frequent Flares","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":313,"lead_sponsor_name":"Changchun GeneScience Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06966635","title":"Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":312,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT06887452","title":"Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With Gout","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":310,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT05275348","title":"Delivery of Enhance Fitness Trial","phase":"NA","overall_status":"UNKNOWN","enrollment_count":310,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT02741700","title":"SToRytelling to Improve DiseasE Outcomes in GOut: The STRIDE-GO2 Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":306,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT04734093","title":"Sonographic Signs of Gouty Arthritis in a Cohort of Egyptian Patients: a Cross Sectional Multicenter Study","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT05658575","title":"Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Olatec Therapeutics LLC","has_results":false},{"nct_id":"NCT05818085","title":"Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Atom Therapeutics Co., Ltd","has_results":false},{"nct_id":"NCT02950142","title":"Evidence-based Laboratory Test Order Sets in Primary Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":288,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT06880653","title":"Dose Response of Exercise for Arthritis Management","phase":"NA","overall_status":"RECRUITING","enrollment_count":285,"lead_sponsor_name":"University of South Carolina","has_results":false},{"nct_id":"NCT04130204","title":"Topical Application to Relieve Gout: Efficacy Trial & Safety (TARGETS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":284,"lead_sponsor_name":"Dyve Biosciences, Inc.","has_results":false},{"nct_id":"NCT07388498","title":"A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":270,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT05289544","title":"Phone-Based Based Walk With Ease Program for Adults With Arthritis","phase":"NA","overall_status":"COMPLETED","enrollment_count":267,"lead_sponsor_name":"University of South Carolina","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}